Name | 3,4-dihydro-2H-chromen-2-ylmethanamine |
---|---|
Synonyms |
(+/-)-3,4-dihydro-2H-chromen-2-ylmethylamine
C-CHROMAN-2-YL-METHYLAMINE 3,4-dihydro-2H-1-benzopyran-2-methanamine aminomethyl-chroman QC-3073 2-aminomethyl-3,4-dihydro-2H-chromene Chroman-2-ylmethanamine [(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]amine (chroman-2-ylmethyl)amine 2-aminomethyl-chromane |
Molecular Formula | C10H13NO |
---|---|
Molecular Weight | 163.21600 |
Exact Mass | 163.10000 |
PSA | 35.25000 |
LogP | 2.03920 |
~70% 3990-59-8 |
Literature: McComsey, David F.; Smith-Swintosky, Virginia L.; Parker, Michael H.; Brenneman, Douglas E.; Malatynska, Ewa; White, H. Steve; Klein, Brian D.; Wilcox, Karen S.; Milewski, Michael E.; Herb, Mark; Finley, Michael F. A.; Liu, Yi; Lubin, Mary Lou; Qin, Ning; Reitz, Allen B.; Maryanoff, Bruce E. Journal of Medicinal Chemistry, 2013 , vol. 56, # 22 p. 9019 - 9030 |
~% 3990-59-8 |
Literature: Maryanoff, Bruce E.; McComsey, David F.; Costanzo, Michael J.; Hochman, Coralie; Smith-Swintosky, Virginia; Shank, Richard P. Journal of Medicinal Chemistry, 2005 , vol. 48, # 6 p. 1941 - 1947 |
~% 3990-59-8 |
Literature: Gomtsyan, Arthur; Bayburt, Erol K.; Schmidt, Robert G.; Lee, Chih-Hung; Brown, Brian S.; Jinkerson, Tammie K.; Koenig, John R.; Daanen, Jerome F.; Latshaw, Steven P. Patent: US2006/128689 A1, 2006 ; Location in patent: Page/Page column 20 ; |
~64% 3990-59-8 |
Literature: Janssen Pharmaceutica, N.V. Patent: US5824682 A1, 1998 ; US 5824682 A |
~% 3990-59-8 |
Literature: Bristol-Myers Squibb Patent: US5391570 A1, 1995 ; US 5391570 A |
Precursor 5 | |
---|---|
DownStream 0 |